RMTI Rockwell Medical Inc.

2.69
+0.12  (+5%)
Previous Close 2.57
Open 2.55
Price To Book 7.27
Market Cap 172,041,352
Shares 63,955,893
Volume 360,819
Short Ratio
Av. Daily Volume 414,899
Stock charts supplied by TradingView

NewsSee all news

  1. Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India

    WIXOM, Mich., Jan. 14, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes

  2. Rockwell Medical, Inc. Appoints Russell H. Ellison, MD, MSc, to Board of Directors

    WIXOM, Mich., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving

  3. Rockwell Medical, Inc. to Present at Biotech Showcase 2020

    WIXOM, Mich., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, and Angus Smith,

  4. Rockwell Medical, Inc. to Present at 31st Annual Piper Jaffray Healthcare Conference

    WIXOM, Mich., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the

  5. Rockwell Medical, Inc. Expands Medical Capabilities

    – Company adds experienced medical executive to management team and leading nephrologists to Medical Advisory Board – – Objective to become a leading medical organization in the field of dialysis – WIXOM, Mich., Nov.

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Approved January 26, 2015.
Soluble Ferric Pyrophosphate
Anemia
PDUFA date March 28, 2020.
IV Triferic
Anemia

Latest News

  1. Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India

    WIXOM, Mich., Jan. 14, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes

  2. Rockwell Medical, Inc. Appoints Russell H. Ellison, MD, MSc, to Board of Directors

    WIXOM, Mich., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving

  3. Rockwell Medical, Inc. to Present at Biotech Showcase 2020

    WIXOM, Mich., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, and Angus Smith,

  4. Rockwell Medical, Inc. to Present at 31st Annual Piper Jaffray Healthcare Conference

    WIXOM, Mich., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the

  5. Rockwell Medical, Inc. Expands Medical Capabilities

    – Company adds experienced medical executive to management team and leading nephrologists to Medical Advisory Board – – Objective to become a leading medical organization in the field of dialysis – WIXOM, Mich., Nov.

  6. Rockwell Medical, Inc. Reports Third Quarter 2019 Financial Results

    – Company reports first full quarter of results for Dialysate Triferic, highlighted by greater than 75% conversion rate from Triferic Evaluation Program –  – Signs leading East Coast academic medical center as first

  7. Rockwell Medical, Inc. to Sponsor Triferic® Exhibitor Spotlight Presentation at American Society of Nephrology Conference

    WIXOM, Mich., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an

  8. Rockwell Medical, Inc. to Discuss Third Quarter 2019 Financial Results on November 11, 2019

    WIXOM, Mich., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the "Company") (NASDAQ:RMTI) today announced that the Company will release its 2019 third quarter financial results on

  9. Rockwell Medical, Inc. Appoints John P. McLaughlin Chairman of the Board of Directors

    WIXOM, Mich., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an

  10. Rockwell Medical, Inc. Provides Business Update

    –  Encouraging progress for Triferic® portfolio – – Conference call at 8:30 am ET on Friday, October 25, 2019 – WIXOM, Mich., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical"

  11. Rockwell Medical, Inc. to Present at 2019 Cantor Global Healthcare Conference

    WIXOM, Mich., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to

  12. Rockwell Medical, Inc. Appoints Industry Veteran John P. McLaughlin to Board of Directors

    WIXOM, Mich., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia,

  13. Rockwell Medical, Inc. to Present at Upcoming September Conferences

    WIXOM, Mich., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to